Alnylam Pharmaceuticals (ALNY) PT Lowered to $415 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $292.58 +2.26%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Patrick Trucchio lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $415.00 (from $430.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Abivax (ABVX) PT Lowered to $136 at Wolfe Research
- Citi Downgrades Ecopetrol SA (EC) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
